Financial News for Top Biotechnology, Medical Device and Pharmaceutical Companies

Daily Career Advice from the News SharkSubscribe today for jobs, breaking medical news and career advice from top medical recruiters.

A Form SC 13G/A regarding Gilead Sciences has been filed with the United States Securities and Exchange Commission.

To View the filing please click here

If you are unable to click on the link above, please copy and paste the URL below into a web browser

NASDAQ OMX 325 Donald J. Lynch Blvd, Marlborough, MA 01752 | 800/990-6397

Invitation to Capio’s capital market day in Stockholm on March 15, 2016

Capio AB (publ) invites investors, financial analysts and media to the Group’s capital market day on March 15, 2016 at Capio St. Göran’s hospital (auditorium) in Stockholm, Sweden.

During the capital market day presentations about the Capio strategy and business operations will be given by Thomas Berglund, president and CEO, and other members of Capio’s Group Management. The program will also include presentations of the strategy in action in some of the Group’s largest business areas as well as a walk through Capio St. Göran’s hospital.

To participate, please register at A detailed agenda will be sent to participants well in advance of March 15.

We look forward to your participation.

For information, please contact:

Proposed changes in composition of the Board of Directors of Novo Nordisk A/S

The Annual General Meeting of Novo Nordisk A/S is planned to be held on Friday 18 March 2016. 

All board members elected by the Annual General Meeting are up for election. Thomas Paul Koestler and Eivind Kolding do not seek re-election.

At the Annual General Meeting, the Board of Directors proposes re-election of the following board members elected by the shareholders: Göran Ando (chairman), Jeppe Christiansen (vice chairman), Bruno Angelici, Sylvie Grégoire, Liz Hewitt and Mary Szela. 

Furthermore, the Board of Directors proposes that Brian Daniels is elected as new member to the Board of Directors. 

Brian Daniels, MD, is a senior advisor with the Boston Consulting Group and venture partner with 5AM Venture Management, LLC, both in the US. The Board of Directors recommends election of Brian Daniels because of his extensive experience in clinical development, medical affairs and corporate strategy across a broad range of therapeutics areas within the pharmaceutical industry, especially in the US.

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX) today declared a regular quarterly dividend of $0.115 per Baxter common share. This cash dividend is payable on April 1, 2016 to shareholders of record as of March 4, 2016. read more

Get Med Career News in your Inbox!

If you want to keep up with the latest news and career tips in the Medical Field subscribe today!

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.